About Synexa Life Sciences
Synexa Life Sciences is a company based in Cape Town (South Africa) founded in 2003. Synexa Life Sciences has completed 2 acquisitions, including Alderley Analytical and Syrinx Bioanalytics. Synexa Life Sciences offers products and services including Translational Flow Cytometry, ELISpot Biomarkers, Clinical Bioanalysis, Radiopharmaceutical Bioanalysis, and Genomics. Synexa Life Sciences operates in a competitive market with competitors including Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and BioAgilytix, among others.
- Headquarter Cape Town, South Africa
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synexa Life Sciences Bv
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Alderley Analytical
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synexa Life Sciences
Synexa Life Sciences offers a comprehensive portfolio of products and services, including Translational Flow Cytometry, ELISpot Biomarkers, Clinical Bioanalysis, Radiopharmaceutical Bioanalysis, and Genomics.
Develops and validates assays for immune cell analysis in trials.
Detects antigen-specific immune responses for disease research.
Analyzes large molecules for clinical sample testing.
Supports radiopharmaceutical development for therapies.
Provides precise assays for genetic analysis in research.
People of Synexa Life Sciences
Unlock access to complete
Funding Insights of Synexa Life Sciences
Detailed funding history for Synexa Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synexa Life Sciences
Synexa Life Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Alderley Analytical and Syrinx Bioanalytics.
Investment portfolio details for Synexa Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bioanalytical assays for drug development are developed and validated.
|
Locked | Locked | 2013 | Locked | |
|
Bioanalytical immunoassay services for biologics and biomarkers are provided.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Synexa Life Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Synexa Life Sciences
Detailed financials for Synexa Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synexa Life Sciences Comparisons
Peer comparison for Synexa Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synexa Life Sciences
Synexa Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and BioAgilytix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
Detailed competitors of Synexa Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synexa Life Sciences
Complete news archive for Synexa Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synexa Life Sciences
Synexa Life Sciences was founded in 2003.
Synexa Life Sciences is headquartered in Cape Town, South Africa. It is registered at Cape Town, Western Cape, South Africa.
Synexa Life Sciences offers analytical and advisory services to pharma and biotech companies mainly in the development and analysis of biomarkers in clinical trials and diagnostic validation programs. They help companies in formulating a biomarker strategy, assay development and validation, sample analysis and also by offering bioinformatics solutions. Their proprietary approach called ProtoTrials is an in vitro translational immunology study conducted on human samples (both healthy and patient volunteers) that can offer insights into the efficacy, safety and MOA of a drug. Their assay portfolio includes immunoassays, flow cytometry,culture based assays, liquid biopsies and lymphosure (QA standard for flow cytometric analysis of lymphocyte subsets). Synexa also offers bioanalytical chemistry and genotyping and gene expression profiling services.
Synexa Life Sciences's top competitors include Novogene Corporation, BGI and BioAgilytix.
Synexa Life Sciences offers Translational Flow Cytometry, ELISpot Biomarkers, Clinical Bioanalysis, Radiopharmaceutical Bioanalysis, and Genomics.
Synexa Life Sciences has made 2 acquisitions, including Alderley Analytical, and Syrinx Bioanalytics.